# Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm

> **NCT00873015** · PHASE2 · COMPLETED · sponsor: **Hope Pharmaceuticals** · enrollment: 19 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Sodium nitrite
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00873015
- **Lead sponsor:** Hope Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-11
- **Final completion:** 2012-08
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00873015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00873015, "Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00873015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*